BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  National Research Council of Canada And Lexaria Bioscience Corp. Commence Laboratory Work

  July 21, 2017

   · 

  4 min read
• Drug Development

  SillaJen And Lee’s Pharmaceutical Announce Approval By The China CFDA To Commence Phase III Clinical Trial For Oncolytic Immunotherapy, Pexa-Vec, In Liver Cancer

  July 21, 2017

   · 

  6 min read
• Drug Development

  BrainStorm Cell Awarded $16 Million Non-Dilutive Grant From CIRM In Support Of Phase III Clinical Trial Of NurOwn In ALS

  July 21, 2017

   · 

  4 min read
• Business

  VLP Therapeutics Appoints Jacob Licht As Chief Operating Officer

  July 21, 2017

   · 

  3 min read
• Ipsen Receives Positive CHMP Opinion For Approval Of Xermelo (Telotristat Ethyl), For The Treatment Of Carcinoid Syndrome Diarrhea In Patients Inadequately Controlled By Somatostatin Analogue Therapy

  July 21, 2017

   · 

  12 min read
• Business

  Ophthotech To Report Second Quarter 2017 Financial Results And Host Conference Call On Wednesday, July 26, 2017

  July 21, 2017

   · 

  1 min read
• Business

  Cerus To Release Second Quarter 2017 Results On August 3, 2017

  July 21, 2017

   · 

  1 min read
• BioCapital

  Vanda Receives Negative Opinion For Marketing Authorization From The EMA On Fanaptum For The Treatment Of Schizophrenia

  July 21, 2017

   · 

  3 min read
• Business

  ArQule To Report Second Quarter 2017 Financial Results On August 4, 2017

  July 21, 2017

   · 

  2 min read
• Business

  Ligand To Report Second Quarter 2017 Results On August 7th

  July 21, 2017

   · 

  1 min read